A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

Goutagny Stephane; Giovannini Marco; Kalamarides Michel

首页> 外文期刊>Journal of neuro-oncology. >A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

【24h】

A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

机译：NF2患者中血管血症的4年期II研究，NF2患者中前庭施韦马斯

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of neuro-oncology.》 |2017年第2期|共3页
作者
Goutagny Stephane; Giovannini Marco; Kalamarides Michel;
展开▼
作者单位

Hop Beaujon AP HP 100 Blvd Gen Leclerc F-92100 Clichy France;

Univ Calif Los Angeles 10833 Le Conte Ave Los Angeles CA 90095 USA;

Hop La Pitie Salpetriere AP HP Neurochirurgie 47-83 Blvd Hop F-75013 Paris France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas [J] . Goutagny Stephane, Giovannini Marco, Kalamarides Michel Journal of neuro-oncology. . 2017,第2期

机译：NF2患者中血管血症的4年期II研究，NF2患者中前庭施韦马斯
2. A Phase 0 Pharmacodynamic and Pharmacokinetic Study of Everolimus in Vestibular Schwannoma (VS) and Meningioma Patients [J] . Karajannis M., Wang S., Goldberg J., Pediatric blood & cancer . 2019,第S4期

机译：前庭施瓦新瘤（VS）和脑膜瘤患者血模秋司的0阶段药效和药代动力学研究
3. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas [J] . Kruyt Ivo J., Verheul Jeroen B., Hanssens Patrick E. J., Journal of neurosurgery. . 2018,第1期

机译：伽马刀放射外科治疗神经纤维瘤病患者生长前庭施沃马斯2型：与零星前庭施瓦莫马瘤的竞争队列研究
4. Efficacy Analysis of Preservative-Free Tafluprost and Timolol in Open-Angle Glaucoma and OHT Patients in a Phase-III Study [C] . GrundenJ., Lupinacci R. International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：在第三阶段研究中，在开放角度荧光眼和OHT患者中无防腐型TaFluprost和蒂莫尔的疗效分析
5. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-Clinical Mechanistic Assessment [D] . Moorthy, Ganesh P. 2015

机译：BEZ235，PI3K / mTOR抑制剂和依维莫司，mTOR抑制剂的新型组合的临床药代动力学：I期临床研究和非临床机制评估
6. Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas [O] . Matthias A. Karajannis, Geneviève Legault, Mari Hagiwara, 2014

机译：儿童和成人2型神经纤维瘤病和进行性前庭神经鞘瘤的依维莫司II期研究
7. Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas [O] . Stéphane Goutagny, Eric Raymond, Marina Esposito-Farese, 2015

机译：MTORC1抑制MTORC1在神经纤维瘤病毒中的抑制作用2型生长前庭Schwannomas患者

A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas

著录项

相似文献

相关主题

期刊订阅